Clinical Trials Logo

Egypt clinical trials

View clinical trials related to Egypt.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04898244 Completed - Egypt Clinical Trials

Obstetricians' Views on the Reasons for Egypt's High Caesarean Section Rates

Start date: August 12, 2018
Phase:
Study type: Observational [Patient Registry]

Handling of questionnaires to a number of obstetricians from different hospitals to show their perceptions about causes of high cs rate in Egypt

NCT ID: NCT04816942 Completed - Covid19 Clinical Trials

Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt

Start date: April 23, 2020
Phase: Phase 3
Study type: Interventional

One investigational treatment being explored for COVID-19 is the use of convalescent plasma collected from individuals who have recovered from COVID-19 (Refs. 1-4). Convalescent plasma that contains antibodies to severe acute respiratory syndrome coronavirus 2 or SARSCoV-2 (the virus that causes COVID-19) is being studied for administration to patients with COVID-19. Use of convalescent plasma has been studied in outbreaks of other respiratory infections, including the 2003 SARS-CoV-1 epidemic, the 2009-2010 H1N1 influenza virus pandemic, and the 2012 MERS-CoV epidemic (Refs. 5-7). Although promising, convalescent plasma has not yet been shown to be safe and effective as a treatment for COVID-19. Therefore, it is important to study the safety and efficacy of COVID19 convalescent plasma in clinical trials. This guidance provides recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency. This guidance also provides recommendations to blood establishments on the collection of COVID-19 convalescent plasma..